Skip to main content

Standard Biotools Inc.

LAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001162194

No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.

Q1 2022 vs. Q4 2021

How the institutions holding Standard Biotools Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of LAB: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders121109−12
Shares56.3M50.0M−6.32M (−11.2%)
Value$220.4M$179.5M−$40.9M (−18.6%)

New holders (12)

Institutions that held Standard Biotools Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to LAB in Q1 2022
InstitutionSharesValue% of portfolio
Pura Vida Investments, LLC850,000$3.05M0.37%
Fred Alger Management, LLC400,288$1.44M0.00%
Price Michael F65,000$233.0K0.03%
Virtu Financial LLC14,270$51.0K0.00%
Panagora Asset Management Inc11,555$41.0K0.00%
Amalgamated Financial Corp.9,549$34.0K0.00%
IFP Advisors, Inc2,537$14.0K0.00%
FMR LLC3,603$13.0K0.00%
Aquatic Capital Management LLC1,000$4.00K0.01%
EverSource Wealth Advisors, LLC917$3.00K0.00%
Blue Bell Private Wealth Management, LLC200$1.00K0.00%
Ellevest, Inc.38$00.00%

Sold out (24)

Institutions that held Standard Biotools Inc. at the end of Q4 2021 and filed for Q1 2022 without it.